Insider Selling: Lori Freedman Sells 7,900 Shares of pSivida Corp Stock (PSDV)
pSivida Corp (NASDAQ:PSDV) VP Lori Freedman unloaded 7,900 shares of the company’s stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $4.00, for a total value of $31,600.00. Following the completion of the sale, the vice president now directly owns 96,423 shares in the company, valued at approximately $385,692. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $5.43.
Shares of pSivida Corp (NASDAQ:PSDV) opened at 4.04 on Friday. pSivida Corp has a 52-week low of $2.28 and a 52-week high of $5.60. The stock has a 50-day moving average of $3.75 and a 200-day moving average of $3.95. The company’s market cap is $118.2 million.
pSivida Corp (NASDAQ:PSDV) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. Analysts expect that pSivida Corp will post $-0.69 EPS for the current fiscal year.
pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.